Lloyds TSB Group PLC
29 May 2003
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
1. Name of company
LLOYDS TSB GROUP plc
2. Name of director
MICHAEL DAVID ROSS
3. Please state whether notification indicates that it is in respect of holding
of the shareholder named in 2 above or in respect of a non-beneficial interest
or in the case of an individual holder if it is a holding of that person's
spouse or children under the age of 18 or in respect of a non-beneficial
interest
HOLDING OF DIRECTOR
4. Name of the registered holder(s) and, if more than one holder, the number of
shares held by each of them (if notified)
AS MENTIONED IN SECTION 2
5. Please state whether notification relates to a person(s) connected with the
director named in 2 above and identify the connected person(s)
SEE SECTION 6
6. Please state the nature of the transaction. For PEP transactions please
indicate whether general/single co PEP and if discretionary/non discretionary
732 shares were allocated to Lloyds TSB Registrars Corporate
Nominee Limited AESOP1 account (LTSBRCNL AESOP1) for Mr.
Ross under the Lloyds TSB Group Shareplan on 28th April,
2003 at 409.4p per share.
Notices giving details were posted to participants in the
Lloyds TSB Group Shareplan by the trustee and the director
notified the company within 5 business days following his
being made aware of the details.
7. Number of shares/amount of stock acquired
SEE SECTION 6
8. Percentage of issued class
MINIMAL
9. Number of shares/amount of stock disposed
N/A
10. Percentage of issued class
N/A
11. Class of security
ORDINARY SHARES OF 25p EACH
12. Price per share
SEE SECTION 6
13. Date of transaction
SEE SECTION 6
14. Date company informed
SEE SECTION 6
15. Total holding following this notification
MR. M.D. ROSS: 2,500
LTSBRCNL AESOP1: 732
16. Total percentage holding of issued class following this notification
MINIMAL
If a director has been granted options by the company please complete the
following boxes.
17. Date of grant
-
18. Period during which or date on which exercisable
-
19. Total amount paid (if any) for grant of the option
-
20. Description of shares or debentures involved: class, number
21. Exercise price (if fixed at time of grant) or indication that price is to be
fixed at time of exercise
-
22. Total number of shares or debentures over which options held following this
notification
1,345,838
23. Any additional information
-
24. Name of contact and telephone number for queries
A.J. MICHIE, SECRETARY 020 7356 1043
25. Name and signature of authorised company official responsible for making
this notification
A.J. MICHIE, SECRETARY
Date of Notification
29TH MAY, 2003
The FSA does not give any express or implied warranty as to the accuracy of this
document or material and does not accept any liability for error or omission.
The FSA is not liable for any damages (including, without limitation, damages
for loss of business or loss of profits) arising in contract, tort or otherwise
from the use of or inability to use this document, or any material contained in
it, or from any action or decision taken as a result of using this document or
any such material.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.